Literature DB >> 34131070

The Prognostic Potential of Human Prostate Cancer-Associated Macrophage Subtypes as Revealed by Single-Cell Transcriptomics.

Joseph C Siefert1,2, Bianca Cioni1, Mauro J Muraro3,4, Mohammed Alshalalfa5, Judith Vivié3,4, Henk G van der Poel6, Ivo G Schoots7, Elise Bekers8, Felix Y Feng5, Lodewyk F A Wessels9,10, Wilbert Zwart11,10, Andries M Bergman11,12.   

Abstract

Macrophages in the tumor microenvironment are causally linked with prostate cancer development and progression, yet little is known about their composition in neoplastic human tissue. By performing single cell transcriptomic analysis of human prostate cancer resident macrophages, three distinct populations were identified in the diseased prostate. Unexpectedly, no differences were observed between macrophages isolated from the tumorous and nontumorous portions of the prostatectomy specimens. Markers associated with canonical M1 and M2 macrophage phenotypes were identifiable, however these were not the main factors defining unique subtypes. The genes selectively associated with each macrophage cluster were used to develop a gene signature which was highly associated with both recurrence-free and metastasis-free survival. These results highlight the relevance of tissue-specific macrophage subtypes in the tumor microenvironment for prostate cancer progression and demonstrates the utility of profiling single-cell transcriptomics in human tumor samples as a strategy to design gene classifiers for patient prognostication. IMPLICATIONS: The specific macrophage subtypes present in a diseased human prostate have prognostic value, suggesting that the relative proportions of these populations are related to patient outcome. Understanding the relative contributions of these subtypes will not only inform patient prognostication, but will enable personalized immunotherapeutic strategies to increase beneficial populations or reduce detrimental populations. ©2021 The Authors; Published by the American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34131070     DOI: 10.1158/1541-7786.MCR-20-0740

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  2 in total

Review 1.  Understanding and targeting prostate cancer cell heterogeneity and plasticity.

Authors:  Dean G Tang
Journal:  Semin Cancer Biol       Date:  2021-11-26       Impact factor: 17.012

2.  Blockade of exosome generation by GW4869 inhibits the education of M2 macrophages in prostate cancer.

Authors:  Yilin Peng; Min Zhao; Yinying Hu; Hongyan Guo; Yanyan Zhang; Yanqin Huang; Lin Zhao; Yong Chai; Zhigang Wang
Journal:  BMC Immunol       Date:  2022-08-08       Impact factor: 3.594

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.